Multiple Sclerosis Resource Centre

Welcome to the Multiple Sclerosis Resource Centre. This website is intended for international healthcare professionals with an interest in Multiple Sclerosis. By clicking the link below you are declaring and confirming that you are a healthcare professional

Introduction


Welcome to the Multiple Sclerosis Resource Centre. The Resource Centre provides you with free access to the latest peer-reviewed clinical information relating to the treatment of Multiple Sclerosis.

What is a Resource Centre?

A Resource Centre is a freely accessible platform that aims to increase clinical knowledge in a specific medical specialty by disseminating important new research and clinical developments more broadly. All content on this platform is independently selected and reviewed by the Resource Centre’s editor, Professor Tim Vartanian from Cornell University. This resource is provided by the journal, Multiple Sclerosis and Related Disorders, published by Elsevier, and made possible by a donation from EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.


About the Editors

  • Prof Timothy Vartanian

    Timothy Vartanian, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell...
  • Dr Claire S. Riley

    Claire S. Riley, MD is an assistant attending neurologist and assistant professor of neurology in the Neurological Institute, Columbia University,...

Upcoming Congresses

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe »

This online Resource Centre has been made possible by a donation from EMD Serono, Inc, a subsidiary of Merck KGaA, Darmstadt, Germany and from Pfizer Inc.

Note that EMD Serono, Inc. and Pfizer Inc have had no editorial control or influence over the content of this Resource Centre. The Resource Centre and all content therein have been subject to an independent editorial review

The Grant for Multiple Sclerosis Innovation
supports promising translational research projects by academic researchers to improve understanding of multiple sclerosis (MS) for the ultimate benefit of patients.  For full information and application details, please click here

Journal Editor's choice

Multiple Sclerosis and Related Disorders ; Volume 3, Issue 2

Prof. Gavin Giovannoni

Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis
D.R. Altmann, K. Schmierer, K. Hunter, D.J. Tozer, C.A. Wheeler-Kingshott, A. Coles, D.H. Miller
Multiple Sclerosis and Related Disorders, April 2014, Vol 3 Issue 2.

Search this site

Search form